Newsroom

Sorted by: Latest

-

Cary Street Partners Plots Major Expansion into Raleigh-Durham Market

RICHMOND, Va.--(BUSINESS WIRE)--Cary Street Partners (“CSP”), the independent wealth management firm based in Richmond, today announced its expansion into Raleigh, North Carolina, through the acquisition of Townsend Asset Management (“Townsend”), a highly regarded regional wealth management team established 45 years ago by Gerald A. Townsend. In addition to already existing North Carolina office locations in Charlotte, Greensboro and Huntersville, this partnership extends the firm’s presence in...
-

Ollin Biosciences and Its Next-Generation Medicines for Patients with Vision-Threatening Eye Diseases to be Acquired

AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (“Ollin”), a privately-held clinical-stage biopharmaceutical company developing therapies for serious eye diseases, today announced it has entered into a definitive agreement to be acquired by Johnson & Johnson for $2.2 billion upfront with the potential for up to approximately $1.1 billion in additional regulatory and commercial milestone payments. Ollin was founded in 2023 with a mission to identify and accelerate the development of...
-

Everforth, Inc. to Offer $500 Million Senior Notes Due 2031

RICHMOND, Va.--(BUSINESS WIRE)--Everforth, Inc. (NYSE: EFOR) (“Everforth”) announced today its intention to offer $500 million in aggregate principal amount of senior notes due 2031 (the “Notes”), subject to market and customary conditions.The Notes will be general unsecured senior obligations of Everforth.Everforth intends to use the net proceeds from the Notes, together with borrowings under its revolving credit facility, to fund the redemption in full of all of Everforth’s outstanding 4.625%...
-

Brighthouse Financial Announces Preferred Stock Dividends and Related Depositary Share Distributions

CHARLOTTE, N.C.--(BUSINESS WIRE)--Brighthouse Financial, Inc. (“Brighthouse Financial” or the “company”) (Nasdaq: BHF) announced today that on December 28, 2026, holders of record as of December 10, 2026 (the “Record Date”) of (i) its depositary shares (the “Series A Depositary Shares” (Nasdaq: BHFAP)), each representing a 1/1,000th interest in a share of its 6.600% Non-Cumulative Preferred Stock, Series A (the “Series A Preferred Stock”), (ii) its depositary shares (the “Series B Depositary Sh...
-

Focus Financial Partners Announces Strategic Capital Investment From Apollo Funds

ST. LOUIS--(BUSINESS WIRE)--Focus Financial Partners (“Focus”), a leading financial services firm comprised of integrated wealth management, family office, and business management services, today announced that it has entered into a definitive agreement with funds managed by affiliates of Apollo ("Apollo Funds"), under which Apollo Funds will provide strategic capital to Focus. Clayton, Dubilier & Rice (“CD&R”) and Stone Point Capital (“Stone Point”) will remain controlling investors in...
-

Lambda Announces World’s First Large-Scale CPO Deployment of NVIDIA Photonics Switches

SAN FRANCISCO--(BUSINESS WIRE)--Lambda, the Superintelligence Cloud, today announced the world’s first large-scale deployment of co-packaged optics (CPO) networking, connecting 10,000+ NVIDIA Blackwell Ultra GPUs using NVIDIA Photonics networking switches at its Quebec campus. Following its early adoption of NVIDIA CPO networking, first announced in November 2025, Lambda benchmarked the technology against conventional optics, demonstrating lower latency and improved signal stability at scale. A...
-

SolarEdge Debuts U.S.-Made Duo Power Optimizer for Commercial and Industrial Projects, Delivering Module-Level Performance with 50% Fewer Units

MILPITAS, Calif.--(BUSINESS WIRE)--SolarEdge unveils the new SolarEdge Duo Power Optimizer for commercial and industrial (C&I) solar installations in the United States...
-

Biocon Gets U.S. FDA Approval for Pebrilzo™ (pertuzumab-qcay) Injection, a Biosimilar to Perjeta®, Expanding Its Oncology Portfolio

BENGALURU, India & BRIDGEWATER, N.J.--(BUSINESS WIRE)--Biocon secures U.S. FDA Approval for Pebrilzo™ (pertuzumab-qcay) Injection, a Biosimilar to Perjeta®, expand the company's oncology portfolio...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 13.11.2026 FXGB LN IE00BD5HBR05   79,467.00 GBP   1,729,665.89   28.776  ...
-

Hydra Host Open Sources Hydra OS™, the Global AI Factory Operating System.

BOULDER, Colo.--(BUSINESS WIRE)--Hydra Host is introducing Hydra OS™ (formerly Brokkr OS), its AI factory operating system, as open source. Built over five years and proven across 50+ data centers worldwide, Hydra OS gives operators the complete software stack to turn racks of AI infrastructure into a revenue-generating AI factory. The repository, documentation, and installable release will be available on GitHub on November 30, 2026. The AI buildout has a software problem that is compounding o...